Drs. Gudrun Rappold and Henning Frohlich from Heidelberg University will discuss their research on the potential benefits of a PDE10A inhibitor for individuals with FOXP1 Syndrome.

Join your host, Kate Lester Mowery to share concerns, ideas, questions, therapies, and laughter with parents of FOXP1 children.